Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer. Web Site AdminNov 8, 20241 min readAtilla Soran, MD, MPH, FNCBC, Ozgur Aytac, MD, FEBS and Serdar Ozbas, MD, FEBS
Nodal Burden and Oncologic Outcomes in Patients WithResidual Isolated Tumor Cells After NeoadjuvantChemotherapy (ypN0i1): The OPBC-05/ICARO Study
Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02
Comments